Back
CRISPR Therapeutics AG Vs. Intellia Therapeutics Industry Stock Comparison
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
49.41
Seasonality Move:
3.26%
Sell
29
NTLA
Intellia Therapeutics
Last Price:
22.92
Seasonality Move:
-1.88%
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $49.55. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.52. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $49.55
The current trend is relatively stagnant and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | -1124988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.74 - 49.2) | Buy |
| Bollinger Bands (100): | (48.75 - 58.61) | Sell |
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 52.84 | Buy |
| Chaikin Money Flow: | -1122879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.84 - 23.26) | Buy |
| Bollinger Bands (100): | (21.77 - 25.41) | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.24 | Buy |
| 20-day SMA: | 47.24 | Buy |
| 50-day SMA: | 50.94 | Sell |
| 200-day SMA: | 60.86 | Sell |
| 8-day EMA: | 47.92 | Buy |
| 20-day EMA: | 47.76 | Buy |
| 50-day EMA: | 50.17 | Sell |
| 200-day EMA: | 56.34 | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.19 | Buy |
| 20-day SMA: | 21.88 | Buy |
| 50-day SMA: | 23.39 | Sell |
| 200-day SMA: | 25.55 | Sell |
| 8-day EMA: | 21.69 | Buy |
| 20-day EMA: | 21.84 | Buy |
| 50-day EMA: | 22.71 | Sell |
| 200-day EMA: | 26.09 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.
CRISPR Therapeutics AG Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intellia Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||